OPKO Health, Inc. 13D and 13G filings for Cocrystal Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-11-19 4:01 pm Purchase | 2020-11-13 | 13D | Cocrystal Pharma, Inc. COCP | OPKO HEALTH INC. OPK | 307,921 5.400% | 781 (+0.25%) | Filing |
| 2020-03-10 4:10 pm Purchase | 2020-02-28 | 13D | Cocrystal Pharma, Inc. COCP | OPKO HEALTH INC. OPK | 307,140 7.800% | 260 (+0.08%) | Filing |